A recent study suggests cannabis might help alleviate some of the liver damage caused by excessive alcohol consumption. The study found that cannabinoids are able to reduce liver toxicity caused by ethanol, the chemical compound found in alcohol. Based on these results, the authors of the study concluded that cannabis might potentially be a treatment for impaired liver function.
Just in time for Dry January, the findings of a recent study suggest that cannabis may be able to help alleviate some of the liver damage caused by excessive alcohol consumption.
The study found that cannabinoids, which are chemical compounds found in cannabis, are able to reduce liver toxicity caused by ethanol, the chemical compound found in alcohol. Based on these results, the authors of the study concluded that cannabis might potentially be a treatment for impaired liver function, also known as hepatotoxicity.
For more news like this, check out our free cannabis news app.
For the study, researchers examined the protective effects of cannabinoids against ethanol-induced (that is, caused by alcohol) liver toxicity in rats.
The animals were divided into seven groups, all of which were treated with different combinations of ethanol and cannabinoids.
An analysis revealed that the groups that were treated with higher doses of cannabinoids showed reduced inflammation compared to animals treated with ethanol alone.
The authors note that levels of the inflammation markers COX-2, CD-14, and MIP-2 showed a “remarkable decrease” in the cannabinoid-treated groups compared to the control groups.
Further analysis showed that cannabinoids acted as inhibitors of mitogen-activated protein kinase pathways, which are involved in cellular responses to stimuli, such as mitogens, osmotic stress, and pro-inflammatory cytokines, as is seen in liver damage due to excess alcohol consumption.
The study concludes, “Our results suggest that cannabinoids are a potential candidate for the treatment of alcohol-induced hepatotoxicity.”
Previous studies have examined the potential of cannabinoids, particularly CBD, as a therapeutic treatment for alcohol use disorder and alcohol-induced liver and brain damage.
A 2019 study found that CBD not only reduced alcohol consumption in people with alcohol use disorder but also reduced alcohol-related steatosis and fibrosis in the liver by “modulating inflammation” and reducing oxidative stress.
A study in late 2017 also pointed to an inverse association between cannabis use and fatty liver disease.
Elsewhere, researchers at the University of Colorado at Boulder and Colorado State University studied the relationship between cannabis use and alcohol use in people enrolled in an alcohol treatment program.
The results, published in the journal Addiction, indicate that on days when these participants used cannabis, their alcohol use decreased significantly. This trend was consistent among those who used large amounts of cannabis and those who used only small amounts occasionally.
—
(Featured image by Chris F via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
A survey found that women comprise 61% of home cannabis growers, marking a diversion from…
Denmark plans to make its pilot medical cannabis program permanent following its success in treating…
Polish lawmakers have submitted a non-binding petition to Prime Minister Donald Tusk, urging cannabis decriminalization…
The UK medical cannabis market has rapidly grown since legalization in 2018, with private actors…
A new study involving over 23,000 participants in New Zealand found that 60% of people…
The French Ministers of the Interior and Justice announced a comprehensive plan to tackle organized…